Name: Pliant Therapeutics, Inc. (PLRX) Financial Statements
Creator: FinSpry

Pliant Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Pliant Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	1.58	9.69	7.57	41.82
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	1.58	9.69	7.57	41.82
Operating Expenses
Research & Development	169.31	127.80	96.94	77.55	66.19
Selling, General & Administrative	59.06	57.93	39.95	27.56	17.27
Operating Expenses	228.37	185.73	136.89	105.11	83.46
Operating Income	-228.37	-184.15	-127.20	-97.54	-41.65
Other Income/Expense
Interest Income	21.09	24.08	4.67	0.27	0.11
Interest Expense	-3.02	-1.27	-0.79	0.00	0.00
Other Income/Expense	18.06	0.00	0.00	0.00	-0.02
Income
Income Before Tax	-210.30	-161.34	-123.32	-97.54	-41.53
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-210.30	-161.34	-123.32	-97.26	-41.53
Net Income - Continuous Operations	-210.30	-161.34	-123.32	-97.26	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-226.24	-182.30	-125.38	-95.73	-40.34
EBIT	-228.37	-184.15	-127.20	-97.26	-41.65
Depreciation & Amortization	2.13	1.84	1.82	1.50	1.31
Earnings Per Share
Basic EPS	-3.00	-3.00	-3.00	-3.00	-2.00
Diluted EPS	-3.00	-3.00	-3.00	-3.00	-2.00
Basic Shares Outstanding	60.54	58.72	42.02	35.85	21.34
Diluted Shares Outstanding	60.54	58.72	42.02	35.85	21.34